logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Martin J.S. Dyer

university of leicester
H指数:91
被引数:2.8万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TLR9-dependent migration identifies different Chronic Lymphocytic Leukemia signaling states under BTK inhibition.

TLR9依赖性迁移识别BTK抑制下慢性淋巴细胞白血病的不同信号状态。

Blood
IF23.1
2026-10-070
PRE
Emma Kennedy; Lauren Stott; Iona Ashworth; Eleni Ladikou; John Jones; Rosalynd Johnston; Aimilia Vareli; Valter Gattei; Antonella Zucchetto; Triantafillos Liloglou; Piers Patten; Sandrine Jayne; Martin J.S. Dyer; Sean Girvan; David A. Cairns; Fabio Simoes; Simon Mitchell; Chris Pepper; Andrea G.S. Pepper
The spectrum of immunoglobulin heavy chain enhancer hijacking in chronic lymphocytic leukemia

慢性淋巴细胞白血病患者免疫球蛋白重链增强子劫持的谱系

Leukemia
IF13.4
2026-04-230
OAAI
Cosima Drewes; Cristina López; Nnamdi Okeke; Billy Jebaraj; Christoph Wiegreffe; Isabelle Kraus; Sina Hillebrecht; Amani Awada; Susanne Bens; Emil Chteinberg; Barbara Eichhorst; Sarah Datismann; Martin J. S. Dyer; Anja Fischer; Kirsten Fischer; Selina Glaser; Michael Hallek; Helene Kretzmer; Anja Mottok; Dominick Pfaff; Karoline Schnitzler; Jan P. Meier-Kolthoff; Matthias Schlesner; Christof Schneider; Stefan Britsch; Ole Ammerpohl; Stephan Stilgenbauer; Eugen Tausch; Reiner Siebert
What does BCL-2 do? From new molecular insights to the clinical implications

BCL-2的功能是什么？从新的分子见解到临床意义

cell death & differentiation
IF0
2026-02-190
PRE
Carlo M. Croce; Stephen W. G. Tait; Ana J. Garcia-Sáez; Andreas Villunger; Anthony Letai; Harriet S. Walter; Martin J. S. Dyer; Douglas R. Green; Yufang Shi; Gerry Melino
The BH3-only protein NOXA is essential for apoptosis induction by BH3-mimetics targeting BCL2 or BCL-XL in DLBCL

BH3-only蛋白NOXA对于靶向BCL2或BCL-XL的BH3模拟物在DLBCL中诱导细胞凋亡是必需的。

British Journal of Haematology
IF3.8
2025-10-050
OAAI
Nahide Yildirim; Marius Anders; Victoria M. Smith; Sandrine Jayne; Moritz Assmann; Rebekah Jukes-Jones; Martin J. S. Dyer; Meike Vogler
In vitro comparison of CD20xCD3 biosimilar antibodies against diffuse large B-cell lymphoma (DLBCL) cell lines with different levels of expression of CD20

体外比较不同CD20表达水平的弥漫性大B细胞淋巴瘤（DLBCL）细胞系中CD20xCD3生物类似抗体的效果

BRITISH JOURNAL OF HAEMATOLOGY
IF3.8
2025-03-031
OAAI
Bray, Joshua S.; Thomas, Gethin R.; Smith, Victoria M.; Wright, Adam; Jayne, Sandrine; Dyer, Martin J. S.; Walter, Harriet S.
Impact of the clinically approved BTK inhibitors on the conformation of full-length BTK and analysis of the development of BTK resistance mutations in chronic lymphocytic leukemia

临床批准的BTK抑制剂对慢性淋巴细胞白血病全长BTK构象的影响及BTK耐药突变的发展分析

ELIFE
IF0
2024-12-271
OAAI
Joseph, Raji E.; Wales, Thomas E.; Jayne, Sandrine; Britton, Robert G.; Fulton, D. Bruce; Engen, John R.; Dyer, Martin J. S.; Andreotti, Amy H.
Comparative in-Vitro Efficacy of CD20xCD3 IgG Bispecific Biosimilar Constructs Against Diffuse Large B Cell Lymphoma (DLBCL) Cell Lines with Different Levels of Expression of CD20

CD20xCD3 IgG双特异性生物类似物构建体对表达不同水平CD20的弥漫性大B细胞淋巴瘤(DLBCL)细胞系的体外比较疗效

BLOOD
IF23.1
2024-11-050
PRE
Bray, Joshua S.; Thomas, Gethin R.; Smith, Victoria M.; Jayne, Sandrine; Dyer, Martin J. S.; Walter, Harriet S.
ASTX295 a Novel Potent MDM2 Antagonist Induces More Than One Mechanism of Programmed Cell Death (PCD) in Lymphoid Malignancies Nishat MSc Sandrine PhD Harriet S. MD PhD MRCP Andrea MD

ASTX295 一种新型强效MDM2拮抗剂在淋巴细胞恶性肿瘤中诱导多种程序性细胞死亡（PCD）机制 Nishat MSc Sandrine PhD Harriet S. MD PhD MRCP Andrea MD

BLOOD
IF23.1
2024-11-050
PRE
Iqbal, Nishat; Jayne, Sandrine; Walter, Harriet S.; Biondo, Andrea; Sims, Martin; Ahn, Maria; Dyer, Martin J. S.
Identification of a novel form of caspase-independent cell death triggered by BH3-mimetics in diffuse large B-cell lymphoma cell lines

在弥漫性大b细胞淋巴瘤细胞系中鉴定由BH3-mimetics触发的新型caspase非依赖性细胞死亡形式

CELL DEATH & DISEASE
IF9.6
2024-04-151
OAAI
Yildirim, Nahide; Sarojam, Lakshmi; Smith, Victoria M.; Pieper, Nadja M.; Anders, Marius; Jackson, Ross A.; Fuhrmann, Dominik C.; Saerchen, Vinzenz; Bruecher, Daniela; Weigert, Andreas; Dyer, Martin J. S.; Vogler, Meike
BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib
BLOOD ADVANCES
IF7.1
2023-07-120
OAAI
Jackson, Ross A.; Britton, Robert G.; Jayne, Sandrine; Lehmann, Susann; Cowley, Caroline M.; Trethewey, Christopher S.; Smith, Victoria M.; Schmid, Ralf; Fegan, Christopher; Walter, Harriet S.; Dyer, Martin J. S.
Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study

Obinutuzumab与利妥昔单抗免疫化疗在先前未经治疗的iNHL中: 镓研究的最终结果

HEMASPHERE
IF14.6
2023-07-0112
OAAI
Townsend, William; Hiddemann, Wolfgang; Buske, Christian; Cartron, Guillaume; Cunningham, David; Dyer, Martin J. S.; Gribben, John G.; Phillips, Elizabeth H.; Dreyling, Martin; Seymour, John F.; Grigg, Andrew; Trotman, Judith; Lin, Tong-Yu; Hong, Xiao-Nan; Kingbiel, Dirk; Nielsen, Tina G.; Knapp, Andrea; Herold, Michael; Marcus, Robert
Computational modeling of DLBCL predicts response to BH3-mimetics
NPJ SYSTEMS BIOLOGY AND APPLICATIONS
IF3.5
2023-06-064
OAAI
Cloete, Ielyaas; Smith, Victoria M.; Jackson, Ross A.; Pepper, Andrea; Pepper, Chris; Vogler, Meike; Dyer, Martin J. S.; Mitchell, Simon
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
BLOOD ADVANCES
IF7.1
2022-08-0428
OAAI
Thompson, Meghan C.; Harrup, Rosemary A.; Coombs, Catherine C.; Roeker, Lindsey E.; Pu, Jeffrey J.; Choi, Michael Y.; Barr, Paul M.; Allan, John N.; Simkovic, Martin; Leslie, Lori; Rhodes, Joanna; Chong, Elise A.; Kamdar, Manali; Skarbnik, Alan; Lansigan, Frederick; McCall, Brittany; Saja, Khalid; Dyer, Martin J. S.; Walter, Harriet S.; Lefebure, Marcus; Thadani-Mulero, Maria; Boyer, Michelle; Biondo, Juliana; Sail, Kavita; Manzoor, Beenish S.; Furman, Richard; Bantilan, Kurt S.; Goy, Andre; Feldman, Tatyana; Labella, Dominic; Schuster, Stephen J.; Park, Jae; Palomba, Lia; Zelenetz, Andrew; Eyre, Toby A.; Kater, Arnon P.; Seymour, John F.; Mato, Anthony R.
Successful Retreatment With Venetoclax in a Patient With Chronic Lymphocytic Leukemia
HEMASPHERE
IF14.6
2022-08-012
OAAI
Jackson, Ross A.; Smith, Victoria M.; Jayne, Sandrine; Drewes, Cosima; Bens, Susanne; Siebert, Reiner; Dyer, Martin J. S.; Walter, Harriet S.
Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study
HAEMATOLOGICA
IF7.9
2021-07-0815
OAAI
Strati, Paolo; de Vos, Sven; Ruan, Jia; Maddocks, J. Kami; Flowers, R. Christopher; Rule, Simon; Patel, Priti; Xu, Yan; Wei, Helen; Frigault, M. Melanie; Calvo, Roser; Dyer, J. S. Martin
Pooled analysis of safety data from clinical trials evaluating acalabrutinib monotherapy in mature B-cell malignancies
LEUKEMIA
IF13.4
2021-04-2734
PREAI
Furman, Richard R.; Byrd, John C.; Owen, Roger G.; O'Brien, Susan M.; Brown, Jennifer R.; Hillmen, Peter; Stephens, Deborah M.; Chernyukhin, Nataliya; Lezhava, Tamara; Hamdy, Ahmed M.; Izumi, Raquel; Patel, Priti; Baek, Marshall; Christian, Beth; Dyer, Martin J. S.; Streetly, Matthew J.; Sun, Clare; Rule, Simon; Wang, Michael; Ghia, Paolo; Jurczak, Wojciech; Pagel, John M.; Sharman, Jeff P.
Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis
LEUKEMIA
IF13.4
2021-02-052
OAAI
Dillon, Richard; Ahearne, Matthew J.; Quek, Lynn; Potter, Nicola; Jovanovic, Jelena; Foot, Nicola; Valganon, Mikel; Jayne, Sandrine; Dennis, Mike; Raj, Kavita; Tauro, Sudhir; Dyer, Martin J. S.; Russell, Nigel; Solomon, Ellen; Grimwade, David
Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features
VIRCHOWS ARCHIV
IF3.1
2021-02-0215
PREAI
Aukema, Sietse M.; Croci, Giorgio A.; Bens, Susanne; Oehl-Huber, Kathrin; Wagener, Rabea; Ott, German; Rosenwald, Andreas; Kluin, Philip M.; van den Berg, Eva; Bosga-Bouwer, Anneke G.; Hoogendoorn, Mels; Hoster, Eva; Bittmann, Iris; Nagel, Inga; Penas, Eva M. Murga; Kreuz, Markus; Bausinger, Julia; Belder, Wilfried; Oschlies, Ilske; Dyer, Martin J. S.; Jayne, Sandrine; Siebert, Reiner; Klapper, Wolfram
Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia
NATURE COMMUNICATIONS
IF15.7
2021-01-287
OAAI
Lin, Wei-Yu; Fordham, Sarah E.; Sunter, Nicola; Elstob, Claire; Rahman, Thahira; Willmore, Elaine; Shepherd, Colin; Strathdee, Gordon; Mainou-Fowler, Tryfonia; Piddock, Rachel; Mearns, Hannah; Barrow, Timothy; Houlston, Richard S.; Marr, Helen; Wallis, Jonathan; Summerfield, Geoffrey; Marshall, Scott; Pettitt, Andrew; Pepper, Christopher; Fegan, Christopher; Forconi, Francesco; Dyer, Martin J. S.; Jayne, Sandrine; Sellors, April; Schuh, Anna; Robbe, Pauline; Oscier, David; Bailey, James; Rais, Syed; Bentley, Alison; Cawkwell, Lynn; Evans, Paul; Hillmen, Peter; Pratt, Guy; Allsup, David J.; Allan, James M.
Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma
LEUKEMIA
IF13.4
2020-12-1716
OAAI
Morschhauser, Franck; Dyer, Martin J. S.; Walter, Harriet S.; Danilov, Alexey V.; Ysebaert, Loic; Hodson, Daniel James; Fegan, Christopher; Rule, Simon A.; Radford, John; Cartron, Guillaume; Bouabdallah, Krimo; Davies, Andrew John; Spurgeon, Stephen; Rajakumaraswamy, Nishanthan; Li, Biao; Humeniuk, Rita; Huang, Xi; Bhargava, Pankaj; Jurgensmeier, Juliane M.; Salles, Gilles

研究方向

暂未获取到该数据
S
Sandrine Jayne
H 指数:27论文数:73被引数:2,039
G
Gerald M. Cohen
H 指数:81论文数:397被引数:3.4万
R
Reiner Siebert
H 指数:108论文数:934被引数:6.8万
D
Daniel Catovsky
H 指数:100论文数:705被引数:4.9万
A
Aneela Majid
H 指数:28论文数:84被引数:3,327
R
Richard S. Houlston
H 指数:120论文数:1,250被引数:6.1万
M
Meike Vogler
H 指数:31论文数:113被引数:4,070
V
Victoria M. Smith
H 指数:13论文数:37被引数:848
C
Claire Dearden
H 指数:51论文数:248被引数:1.0万
E
Estella Matutes
H 指数:79论文数:454被引数:1.9万